Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
Novavax NVAX incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per share.
Revenues in the quarter amounted to $85 million, which beat the Zacks Consensus Estimate of $57 million. However, the top line declined 55% on a year-over-year basis.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
More on NVAX’s Earnings
Novavax recorded $38.2 million in product sales compared with $2.2 million in the year-ago quarter. This upside was primarily driven by sales of the company’s protein-based COVID-19 vaccine, also the company’s sole marketed product, in the United States.
While the reported figure beat our model estimates of $23 million, it missed the Zacks Consensus Estimate of $49 million.
Licensing, royalties and other revenues rose 133% year over year to $46.3 million in the quarter, driven by a combination of activities as part of the recently signed agreement with pharma giant Sanofi SNY for its protein-based COVID-19 vaccine and adjuvant sales.
Starting next year, Sanofi will market the company’s COVID-19 vaccine and also use it to develop novel COVID-19-influenza combination vaccines. As part of this deal, the company received a payment of $570 million from SNY, which includes $70 million in equity investment. NVAX is also eligible to receive milestone payments of up to $700 million and royalties on sales of the COVID-19 vaccine from Sanofi.
Management did not record grant revenues during the quarter. The company reported about $165 million in grant revenues in the year-ago period.
NVAX’s Costs & Cash Balance
In the reported quarter, research and development (R&D) expenses totaled $87 million, down 18% year over year. The downside was caused by a reduction in clinical and manufacturing spending during the quarter.
Selling, general and administrative (SG&A) expenses were down 34% year over year to $71 million, primarily due to management's restructuring activities to reduce costs.
As of Sept. 30, 2024, the company had $924 million of cash and cash equivalents compared with $1.1 billion as of June 30, 2024.
NVAX’s Guidance
For 2024
Novavax expects 2024 total revenues to be in the range of $650-$700 million, down from its previously issued guidance of $700-$800 million. This was likely due to lower COVID-19 vaccine uptake in ex-U.S. markets.
This revised guidance includes nearly $475 million in licensing, royalties and other revenues. This includes $450 million of revenue recognition associated with the $500 million upfront payment from the Sanofi agreement and the rest in royalty and other revenues from partner-related activities.
It expects full-year product revenue guidance of $175-$225 million, down from the earlier projection of $275-$375 million.
Post the earnings release, Novavax’s share price fell 6% on Tuesday likely due to the curtailed guidance. Year to date, the stock has surged 76.2% against the industry’s 0.9% decline.
The company has maintained its projection for full-year combined R&D and SG&A expenses in the band of $700-$750 million.
Beyond 2024
Management has maintained its guidance on combined R&D and SG&A expenses for full-year 2025 and 2026. It expects the combined expenses to be nearly $500 million for 2025 and around $350 million for 2026. It also anticipates a portion of the costs of both these years to be reimbursed by Sanofi.
Updates on NVAX’s Pipeline & Other News
On Monday, Novavax announced that the FDA has lifted the clinical hold on its two pipeline programs, COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine candidates. The agency had initially placed this hold in September after a study participant who took the CIC shot as part of a phase II study reported nerve damage. With this hold removed, management is working with study investigators and other partners to start the phase III immunogenicity study on both vaccines as quickly as possible.
Novavax is on track to complete the database lock of a pediatric clinical study on its COVID-19 vaccine before the end of this year. Achieving this target will trigger a $50-million milestone payment from Sanofi.
A regulatory filing is currently under the FDA’s review seeking full approval for the COVID-19 vaccine, with a final decision expected next year in April. If this filing is approved, it will trigger a $175-million milestone payment from Sanofi.
Novavax is also focused on advancing its pre-clinical programs on pandemic influenza and RSV through investigational new drug (IND) filings. Management intends to focus on exploring RSV-combination options.
Management also signed a deal with an unnamed ‘leading pharmaceutical company’ to use its patented Matrix-M adjuvant with the latter’s pipeline candidates.
NVAX’s Zacks Rank
Novavax currently carries a Zacks Rank #2 (Buy).
Novavax, Inc. Price
Novavax, Inc. price | Novavax, Inc. Quote
Other Key Picks Among Biotech Stocks
Some other top-ranked stocks from the sector are Castle Biosciences CSTL and Biogen BIIB. While CSTL currently sports a Zacks Rank #1 (Strong Buy), BIIB carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, estimates for Castle Biosciences’ 2024 loss per share have narrowed from 58 cents to 8 cents. During the same timeframe, loss per share estimates for 2025 have narrowed from $2.13 to $1.88. Year to date, shares of Castle Biosciences have surged 56.5%.
CSTL’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 172.72%.
In the past 60 days, estimates for Biogen’s 2024 EPS have increased from $16.12 to $16.38. EPS estimates for 2025 have improved from $17.09 to $17.16. Year to date, shares of Biogen have lost 33.5%.
Biogen’s earnings beat estimates in three of the trailing four quarters and missed the mark once, delivering an average surprise of 9.99%.
Zacks Investment Research
December S&P 500 E-Mini futures (ESZ24) are trending down -0.19% this morning as investors held back from making big bets ahead of a crucial U.S. inflation report that could influence the Federal Reserve’s interest rate path.
In yesterday’s trading session, Wall Street’s three main equity benchmarks ended lower. Mosaic slumped over -7% and was the top percentage loser on the S&P 500 after the company reported weaker-than-expected Q3 results. Also, homebuilder stocks lost ground after the benchmark 10-year Treasury yield jumped, with Lennar and D.R. Horton falling more than -3%. In addition, Novavax slid over -6% after cutting its full-year revenue guidance. On the bullish side, Tyson Foods climbed more than +6% and was the top percentage gainer on the S&P 500 after the food giant reported stronger-than-expected FQ4 results. Also, Honeywell International rose over +3% and was the top percentage gainer on the Dow after activist investor Elliott Investment Management built a stake of more than $5 billion and called for a breakup of the industrial giant.
“We are on watch for potential profit taking, consolidation, or even correction for U.S. equities heading into the first quarter of the new year. Upward momentum remains strong and investor sentiment favorable, but stocks are once again overbought/extended across multiple timeframes,” said Dan Wantrobski at Janney Montgomery Scott.
Richmond Fed President Thomas Barkin stated Tuesday that the U.S. economy is “in a good place.” “The Fed is in a position to respond appropriately regardless of how the economy evolves,” he added. Also, Minneapolis Fed President Neel Kashkari said that the central bank might pause its rate-cutting cycle in December if inflation surprises to the upside. “In my judgment, we are still at a modestly contractionary stance, but ultimately the economy will guide us, in terms of how far we are needing to go” in cutting rates, Kashkari said.
In other news, the Federal Reserve’s Senior Loan Officer Opinion Survey, released on Tuesday, showed that U.S. banks saw weaker demand for a key category of business loans in the third quarter, while demand for consumer credit card and auto loans also softened.
Meanwhile, U.S. rate futures have priced in a 65.8% chance of a 25 basis point rate cut and a 34.2% chance of no rate change at the next FOMC meeting in December.
On the earnings front, notable companies like Cisco , Tower Semiconductor , and CyberArk Software are scheduled to release their quarterly results today.
Today, all eyes are focused on the U.S. consumer inflation report, which is set to be released in a couple of hours. Economists, on average, forecast that the U.S. October CPI will come in at +0.2% m/m and +2.6% y/y, compared to the previous numbers of +0.2% m/m and +2.4% y/y.
The U.S. Core CPI will also be closely watched today. Economists anticipate the core CPI to be +0.3% m/m and +3.3% y/y in October, matching September’s figures.
A survey conducted by 22V Research showed that 55% of investors expect the market response to the consumer inflation report to be “mixed/negligible,” 31% anticipate a “risk-off” reaction, and only 14% expect “risk-on.”
In addition, market participants will be looking toward a series of speeches from Fed officials Kashkari, Williams, Logan, Schmid, and Musalem.
In the bond market, the yield on the benchmark 10-year U.S. Treasury note is at 4.414%, down -0.43%.
The Euro Stoxx 50 futures are up +0.13% this morning as investors exercised caution in anticipation of key U.S. inflation data. Technology and automobile stocks lost ground on Wednesday, while energy and mining stocks outperformed. Meanwhile, worries about the impact of Donald Trump’s policies, China’s economic outlook, and the political situation in Germany kept sentiment subdued. Bloomberg reported on Tuesday that German Chancellor Olaf Scholz’s Social Democrats and opposition lawmakers have agreed to hold an early federal election on February 23rd. Market participants are now awaiting a preliminary reading of Eurozone third-quarter GDP as well as the minutes from the European Central Bank’s October policy meeting, set for release on Thursday. In corporate news, Just Eat Takeaway.com N.V. (JET.LN) soared over +21% after announcing a deal to sell its U.S. unit Grubhub to Wonder for $650 million. Also, Siemens Energy Ag surged more than +14% after the utility sector supplier raised its mid-term financial targets.
The European economic data slate is mainly empty on Wednesday.
Asian stock markets today settled mixed. China’s Shanghai Composite Index (SHCOMP) closed up +0.51%, and Japan’s Nikkei 225 Stock Index (NIK) closed down -1.66%.
China’s Shanghai Composite Index closed higher today, recouping losses from earlier in the session. Gains in telecom and media stocks led the overall market higher on Wednesday. The mood improved as Nomura upgraded its China growth forecast, with the Q4 projection adjusted to 4.9% from 4.4% and the annual estimate revised to 4.8% from 4.7%, citing some signs of improving economic activity. Investors also continued to evaluate the economic outlook in China amid weak economic data and a disappointing stimulus package. Meanwhile, Bloomberg reported on Tuesday that China’s securities regulator has increased its interactions with global banks, shifting from quarterly discussions to sometimes weekly or ad-hoc queries to gather perspectives on recent stimulus measures. The initiative to collect data and feedback indicates Beijing’s intensified urgency to rejuvenate the economy. Still, investors remained anxious after reports that U.S. President-elect Donald Trump will nominate China hawks such as Marco Rubio, Mike Waltz, and Kristi Noem to key cabinet positions. In corporate news, OMAT Advanced Materials Guangdong Co. climbed over +8% amid plans to invest 322 million yuan in building an industrial park in Wujiang District, Shaoguan City, China.
Japan’s Nikkei 225 Stock Index closed lower today, tracking overnight losses on Wall Street, while investors also took profits following last week’s rally. Automobile and pharmaceutical stocks led the declines on Wednesday. Data released by the Bank of Japan on Wednesday showed that Japan’s wholesale inflation rose in October at the fastest annual rate in over a year, as recent declines in the yen increased import costs for some goods, complicating the BOJ’s decision on the timing of interest rate hikes. Meanwhile, the yen depreciated past 155 per dollar on Wednesday for the first time since July, increasing the likelihood that Japan will intervene in the currency market to attempt to slow the decline. Investors also continued to assess the impact of the nation’s 10 trillion yen ($65 billion) stimulus plan for AI chipmakers, which is designed to bolster critical supply chains amid ongoing Sino-American trade tensions. In corporate news, Nexon tumbled over -17% after the game maker lowered its full-year net profit guidance. At the same time, Seven & I Holdings climbed more than +11% after the retail giant said it had received a buyout offer from a member of its founding Ito family. Also, Tokyo Electron gained nearly +1% after the chip-making equipment maker boosted its annual operating profit forecast. The Nikkei Volatility, which takes into account the implied volatility of Nikkei 225 options, closed up +7.41% to 24.79.
The Japanese October PPI has been reported at +0.2% m/m and +3.4% y/y, stronger than expectations of 0.0% m/m and +2.9% y/y.
Pre-Market U.S. Stock Movers
Rocket Lab USA soared about +26% in pre-market trading after the company posted better-than-expected Q3 results and issued above-consensus Q4 revenue guidance.
Rivian Automotive surged over +13% in pre-market trading after it formally announced an agreement with Volkswagen Group to create a new joint venture.
Spotify climbed more than +6% in pre-market trading after the music-streaming platform provided a strong Q4 operating income forecast and said it expects to add more users and premium listeners.
CAVA Group advanced over +16% in pre-market trading after posting upbeat Q3 results and raising its annual same restaurant sales growth guidance.
Today’s U.S. Earnings Spotlight: Wednesday - November 13th
Cisco (CSCO), Nu Holdings (NU), Suncor Energy (SU), Tetra Tech (TTEK), Cyberark Software (CYBR), StandardAero (SARO), Loar Holdings LLC (LOAR), Energy of Minas Gerais (CIG), Tower (TSEM), Ultrapar Participacoes (UGP), Alvotech (ALVO), Helmerich Payne (HP), J & J Snack Foods (JJSF), Griffon (GFF), HudBay Minerals (HBM), Kulicke&Soffa (KLIC), Dlocal (DLO), Ibotta (IBTA), Grupo Aval (AVAL), Hillenbrand (HI), Nextnav Acquisition (NN), Tarsus (TARS), Enlight Energy (ENLT), Harrow Health (HROW), Arcos Dorados (ARCO), BrightView Holdings (BV), Callaway Golf (MODG), Sonos (SONO), ARS Pharmaceuticals (SPRY), Dole (DOLE), Afya (AFYA), Paysafe (PSFE), Digi (DGII), Bitfarms (BITF), Kayne Anderson BDC (KBDC), Beazer Homes USA (BZH), Liquidia Technologies (LQDA), Miller Industries (MLR), Capricor Therapeutics (CAPR), Riskified (RSKD).
On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policyhere.
December S&P 500 E-Mini futures (ESZ24) are trending down -0.09% this morning as investors held back from making big bets ahead of a crucial U.S. inflation report that could influence the Federal Reserve’s interest rate path.
In yesterday’s trading session, Wall Street’s three main equity benchmarks ended lower. Mosaic slumped over -7% and was the top percentage loser on the S&P 500 after the company reported weaker-than-expected Q3 results. Also, homebuilder stocks lost ground after the benchmark 10-year Treasury yield jumped, with Lennar and D.R. Horton falling more than -3%. In addition, Novavax slid over -6% after cutting its full-year revenue guidance. On the bullish side, Tyson Foods climbed more than +6% and was the top percentage gainer on the S&P 500 after the food giant reported stronger-than-expected FQ4 results. Also, Honeywell International rose over +3% and was the top percentage gainer on the Dow after activist investor Elliott Investment Management built a stake of more than $5 billion and called for a breakup of the industrial giant.
“We are on watch for potential profit taking, consolidation, or even correction for U.S. equities heading into the first quarter of the new year. Upward momentum remains strong and investor sentiment favorable, but stocks are once again overbought/extended across multiple timeframes,” said Dan Wantrobski at Janney Montgomery Scott.
Richmond Fed President Thomas Barkin stated Tuesday that the U.S. economy is “in a good place.” “The Fed is in a position to respond appropriately regardless of how the economy evolves,” he added. Also, Minneapolis Fed President Neel Kashkari said that the central bank might pause its rate-cutting cycle in December if inflation surprises to the upside. “In my judgment, we are still at a modestly contractionary stance, but ultimately the economy will guide us, in terms of how far we are needing to go” in cutting rates, Kashkari said.
In other news, the Federal Reserve’s Senior Loan Officer Opinion Survey, released on Tuesday, showed that U.S. banks saw weaker demand for a key category of business loans in the third quarter, while demand for consumer credit card and auto loans also softened.
Meanwhile, U.S. rate futures have priced in a 65.8% chance of a 25 basis point rate cut and a 34.2% chance of no rate change at the next FOMC meeting in December.
On the earnings front, notable companies like Cisco , Tower Semiconductor , and CyberArk Software are scheduled to release their quarterly results today.
Today, all eyes are focused on the U.S. consumer inflation report, which is set to be released in a couple of hours. Economists, on average, forecast that the U.S. October CPI will come in at +0.2% m/m and +2.6% y/y, compared to the previous numbers of +0.2% m/m and +2.4% y/y.
The U.S. Core CPI will also be closely watched today. Economists anticipate the core CPI to be +0.3% m/m and +3.3% y/y in October, matching September’s figures.
A survey conducted by 22V Research showed that 55% of investors expect the market response to the consumer inflation report to be “mixed/negligible,” 31% anticipate a “risk-off” reaction, and only 14% expect “risk-on.”
In addition, market participants will be looking toward a series of speeches from Fed officials Kashkari, Williams, Logan, Schmid, and Musalem.
In the bond market, the yield on the benchmark 10-year U.S. Treasury note is at 4.414%, down -0.43%.
The Euro Stoxx 50 futures are up +0.13% this morning as investors exercised caution in anticipation of key U.S. inflation data. Technology and automobile stocks lost ground on Wednesday, while energy and mining stocks outperformed. Meanwhile, worries about the impact of Donald Trump’s policies, China’s economic outlook, and the political situation in Germany kept sentiment subdued. Bloomberg reported on Tuesday that German Chancellor Olaf Scholz’s Social Democrats and opposition lawmakers have agreed to hold an early federal election on February 23rd. Market participants are now awaiting a preliminary reading of Eurozone third-quarter GDP as well as the minutes from the European Central Bank’s October policy meeting, set for release on Thursday. In corporate news, Just Eat Takeaway.com N.V. (JET.LN) soared over +21% after announcing a deal to sell its U.S. unit Grubhub to Wonder for $650 million. Also, Siemens Energy Ag surged more than +14% after the utility sector supplier raised its mid-term financial targets.
The European economic data slate is mainly empty on Wednesday.
Asian stock markets today settled mixed. China’s Shanghai Composite Index (SHCOMP) closed up +0.51%, and Japan’s Nikkei 225 Stock Index (NIK) closed down -1.66%.
China’s Shanghai Composite Index closed higher today, recouping losses from earlier in the session. Gains in telecom and media stocks led the overall market higher on Wednesday. The mood improved as Nomura upgraded its China growth forecast, with the Q4 projection adjusted to 4.9% from 4.4% and the annual estimate revised to 4.8% from 4.7%, citing some signs of improving economic activity. Investors also continued to evaluate the economic outlook in China amid weak economic data and a disappointing stimulus package. Meanwhile, Bloomberg reported on Tuesday that China’s securities regulator has increased its interactions with global banks, shifting from quarterly discussions to sometimes weekly or ad-hoc queries to gather perspectives on recent stimulus measures. The initiative to collect data and feedback indicates Beijing’s intensified urgency to rejuvenate the economy. Still, investors remained anxious after reports that U.S. President-elect Donald Trump will nominate China hawks such as Marco Rubio, Mike Waltz, and Kristi Noem to key cabinet positions. In corporate news, OMAT Advanced Materials Guangdong Co. climbed over +8% amid plans to invest 322 million yuan in building an industrial park in Wujiang District, Shaoguan City, China.
Japan’s Nikkei 225 Stock Index closed lower today, tracking overnight losses on Wall Street, while investors also took profits following last week’s rally. Automobile and pharmaceutical stocks led the declines on Wednesday. Data released by the Bank of Japan on Wednesday showed that Japan’s wholesale inflation rose in October at the fastest annual rate in over a year, as recent declines in the yen increased import costs for some goods, complicating the BOJ’s decision on the timing of interest rate hikes. Meanwhile, the yen depreciated past 155 per dollar on Wednesday for the first time since July, increasing the likelihood that Japan will intervene in the currency market to attempt to slow the decline. Investors also continued to assess the impact of the nation’s 10 trillion yen ($65 billion) stimulus plan for AI chipmakers, which is designed to bolster critical supply chains amid ongoing Sino-American trade tensions. In corporate news, Nexon tumbled over -17% after the game maker lowered its full-year net profit guidance. At the same time, Seven & I Holdings climbed more than +11% after the retail giant said it had received a buyout offer from a member of its founding Ito family. Also, Tokyo Electron gained nearly +1% after the chip-making equipment maker boosted its annual operating profit forecast. The Nikkei Volatility, which takes into account the implied volatility of Nikkei 225 options, closed up +7.41% to 24.79.
The Japanese October PPI has been reported at +0.2% m/m and +3.4% y/y, stronger than expectations of 0.0% m/m and +2.9% y/y.
Pre-Market U.S. Stock Movers
Rocket Lab USA soared about +26% in pre-market trading after the company posted better-than-expected Q3 results and issued above-consensus Q4 revenue guidance.
Spotify climbed more than +6% in pre-market trading after the music-streaming platform provided a strong Q4 operating income forecast and said it expects to add more users and premium listeners.
Today’s U.S. Earnings Spotlight: Wednesday - November 13th
Cisco (CSCO), Nu Holdings (NU), Suncor Energy (SU), Tetra Tech (TTEK), Cyberark Software (CYBR), StandardAero (SARO), Loar Holdings LLC (LOAR), Energy of Minas Gerais (CIG), Tower (TSEM), Ultrapar Participacoes (UGP), Alvotech (ALVO), Helmerich Payne (HP), J & J Snack Foods (JJSF), Griffon (GFF), HudBay Minerals (HBM), Kulicke&Soffa (KLIC), Dlocal (DLO), Ibotta (IBTA), Grupo Aval (AVAL), Hillenbrand (HI), Nextnav Acquisition (NN), Tarsus (TARS), Enlight Energy (ENLT), Harrow Health (HROW), Arcos Dorados (ARCO), BrightView Holdings (BV), Callaway Golf (MODG), Sonos (SONO), ARS Pharmaceuticals (SPRY), Dole (DOLE), Afya (AFYA), Paysafe (PSFE), Digi (DGII), Bitfarms (BITF), Kayne Anderson BDC (KBDC), Beazer Homes USA (BZH), Liquidia Technologies (LQDA), Miller Industries (MLR), Capricor Therapeutics (CAPR), Riskified (RSKD).
On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policyhere.
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.